Paper42801232PubMed
Investigation of the Residual Tumor Burden and Prognosis of Breast Cancer.
Rezende AS and 4 others. Breast Cancer (Dove Med Press), 2026.
Cite this record
ConductScience Library. Investigation of the Residual Tumor Burden and Prognosis of Breast Cancer. Papers, record 42801232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42801232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Investigation of the Residual Tumor Burden and Prognosis of Breast Cancer.
- Journal
- Breast Cancer (Dove Med Press)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-09-28
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28075166 | The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis. | Future Oncol | 2017 | https://conductscience.org/library/papers/28075166 | PubMed |
| 2 | 34902335 | Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. | Lancet Oncol | 2022 | https://conductscience.org/library/papers/34902335 | PubMed |
| 3 | 35626173 | Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35626173 | PubMed |
| 4 | 32202537 | Histological type and typing of breast carcinomas and the WHO classification changes over time. | Pathologica | 2020 | https://conductscience.org/library/papers/32202537 | PubMed |
| 5 | 17443564 | Preoperative chemotherapy for women with operable breast cancer. | Cochrane Database Syst Rev | 2007 | https://conductscience.org/library/papers/17443564 | PubMed |
| 6 | 34620608 | Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy. | J Clin Pathol | 2023 | https://conductscience.org/library/papers/34620608 | PubMed |
| 7 | 17785706 | Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17785706 | PubMed |
| 8 | 34529000 | Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial. | JAMA Oncol | 2021 | https://conductscience.org/library/papers/34529000 | PubMed |
| 9 | 41111043 | Clinical Benefit of Adjuvant Capecitabine According To Residual Cancer Burden in Patients With Triple-Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy. | Clin Breast Cancer | 2026 | https://conductscience.org/library/papers/41111043 | PubMed |
| 10 | 30871490 | Prognostic models for breast cancer: a systematic review. | BMC Cancer | 2019 | https://conductscience.org/library/papers/30871490 | PubMed |
| 11 | 39323311 | Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer Patients Treated With Mastectomy: Indications for Treatment and Oncological Outcomes. | Eur J Breast Health | 2024 | https://conductscience.org/library/papers/39323311 | PubMed |
| 12 | 34288593 | Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. | Cancer Commun (Lond) | 2021 | https://conductscience.org/library/papers/34288593 | PubMed |
| 13 | 32579551 | Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy. | PLoS One | 2020 | https://conductscience.org/library/papers/32579551 | PubMed |
| 14 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 15 | 25932963 | Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy. | Mod Pathol | 2015 | https://conductscience.org/library/papers/25932963 | PubMed |
| 16 | 39362047 | Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study. | Eur J Surg Oncol | 2024 | https://conductscience.org/library/papers/39362047 | PubMed |
| 17 | 20941809 | Biological markers in breast cancer prognosis and treatment. | J BUON | 2010 | https://conductscience.org/library/papers/20941809 | PubMed |
| 18 | 29096890 | Breast Cancer Epidemiology, Prevention, and Screening. | Prog Mol Biol Transl Sci | 2017 | https://conductscience.org/library/papers/29096890 | PubMed |
| 19 | 25114845 | Pathogenesis, prevention, diagnosis and treatment of breast cancer. | World J Clin Oncol | 2014 | https://conductscience.org/library/papers/25114845 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42801232
GET https://conductscience.org/api/papers/v1/42801232/authors